Abdominal Hysterectomy (& Wertheim)
Conditions
Brief summary
Combination of volatile and opioid agents are used to achieve unconsciousness, haemodynamic stability and analgesia for surgical prosedures. This prospective, randomized, double-blind, controlled study evaluates the effects of two different doses of morphine sulphate (0.1 mg/kg and 0.2 mg/kg), on desflurane consumption, recovery characteristics, postoperative analgesic requirements and side effects during total abdominal hysterectomy.
Interventions
Group Saline (Group S): Received i.v saline 0.9 % in 10 ml volume (n=30) Group Morphine 1 (Group M1): Received i.v morphine 0.1 mg kg-1 in 10 ml volume (n=30) Group Morphine 2 (Group M2): Received i.v morphine 0.2 mg kg-1 in 10 ml volume (n=30)
Sponsors
Study design
Eligibility
Inclusion criteria
* undergoing total abdominal hysterectomy with general anaesthesia
Exclusion criteria
* renal dysfunction (cre\>1.2), liver failure, cardiovascular, psychiatric, allergic and metabolic disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| postoperative desflurane consumption | postoperative first hour |
| sedation scores for OASS scale | postoperative first hour |
Countries
Turkey (Türkiye)